12:09 PM EST - BriaCell Therapeutics Corp : Announced a research collaboration agreement with Harvard Medical School in support of a project led by Joan S. Brugge, PhD, a faculty member. The research collaboration will focus on the discovery and development of novel targets to enhance tumor cell responsiveness to chemotherapy and immunotherapies in specific cancers including lung, head and neck, cervical, and bladder cancers. BriaCell Therapeutics Corp
shares T.BCT are trading up $0.03 at $8.08.
